Gottlieb Urges Drug Sponsors to Expand Access to Treatment After Trials

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb and two of his top aides took to the internet Friday to urge drug sponsors to continue treatment for especially needy clinical trial patients after their studies end and before the new treatment is officially approved.

To View This Article:

Login

Subscribe To Drug Industry Daily